A Retrospective, Observational, Multicentric Study Targeted to assess the Effectiveness, Tolerability and Preferred Patient Profile for Fixed Dose Combination of Telmisartan and Metoprolol in Indian Patients with Hypertension (TARGET BETA-2 Study)

This is a real world, retrospective, multicentric, observational study wherein data of patients visiting to various clinics across India are collected in suitably designed Data Collection Form (DCF).

The objective of the study is to retrospectively access the effectiveness, tolerability and preferred patient profiles for FDC of Telmisartan and Metoprolol in the management of Hypertension in real world outpatient settings of India.

STUDY ENDPOINTS are as follows-

1. Primary Endpoints:

• Change in SBP and DBP

1. Secondary Endpoints:

• Change in heart rate in patients with and without tachycardia
• Patient profile and time taken (in years) to switchover to dual therapy from monotherapy.
• Proportion of naïve hypertensives, started with dual therapy

Data for approximately 10,000 patients across India will be collected for the purpose of this study who meets the following criteria-

• Patients who were prescribed FDC of Telmisartan and Metoprolol XR (any dosage)

The present study is a retrospective data collection study. Basic statistical analysis will be performed on all collected data. The data will be compiled, and subjected to analysis.